Literature DB >> 30677142

Diagnosis and management in Pitt-Hopkins syndrome: First international consensus statement.

Marcella Zollino1,2, Christiane Zweier3, Ingrid D Van Balkom4,5, David A Sweetser6, Joseph Alaimo7, Emilia K Bijlsma8, Jannine Cody9, Sarah H Elsea7, Irina Giurgea10, Marina Macchiaiolo11, Robert Smigiel12, Ronald L Thibert13, Ingrid Benoist14, Jill Clayton-Smith15, Channa F De Winter16, Stijn Deckers17, Anusha Gandhi7, Sylvia Huisman18, Dagmar Kempink19, Frea Kruisinga18, Vittoria Lamacchia20, Giuseppe Marangi1,2, Leonie Menke18, Paul Mulder4,5, Ann Nordgren21, Alessandra Renieri20, Sue Routledge22, Carol J Saunders23, Agnieszka Stembalska24, Hans Van Balkom25, Sandra Whalen10, Raoul C Hennekam18.   

Abstract

Pitt-Hopkins syndrome (PTHS) is a neurodevelopmental disorder characterized by intellectual disability, specific facial features, and marked autonomic nervous system dysfunction, especially with disturbances of regulating respiration and intestinal mobility. It is caused by variants in the transcription factor TCF4. Heterogeneity in the clinical and molecular diagnostic criteria and care practices has prompted a group of international experts to establish guidelines for diagnostics and care. For issues, for which there was limited information available in international literature, we collaborated with national support groups and the participants of a syndrome specific international conference to obtain further information. Here, we discuss the resultant consensus, including the clinical definition of PTHS and a molecular diagnostic pathway. Recommendations for managing particular health problems such as dysregulated respiration are provided. We emphasize the need for integration of care for physical and behavioral issues. The recommendations as presented here will need to be evaluated for improvements to allow for continued optimization of diagnostics and care.
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Pitt-Hopkins syndrome; TCF4; autonomic dysfunction; diagnostic criteria; guidelines; molecular diagnostic pathway; syndromic behavior

Mesh:

Substances:

Year:  2019        PMID: 30677142     DOI: 10.1111/cge.13506

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  16 in total

1.  Repurposing the Dihydropyridine Calcium Channel Inhibitor Nicardipine as a Nav1.8 Inhibitor In Vivo for Pitt Hopkins Syndrome.

Authors:  Sean Ekins; Ana C Puhl; Audrey Davidow
Journal:  Pharm Res       Date:  2020-06-11       Impact factor: 4.200

2.  Recommendations by the ClinGen Rett/Angelman-like expert panel for gene-specific variant interpretation methods.

Authors:  Dianalee McKnight; Lora Bean; Izabela Karbassi; Katelynn Beattie; Thierry Bienvenu; Hope Bonin; Ping Fang; John Chrisodoulou; Michael Friez; Maria Helgeson; Rahul Krishnaraj; Linyan Meng; Lindsey Mighion; Jeffrey Neul; Alan Percy; Simon Ramsden; Huda Zoghbi; Soma Das
Journal:  Hum Mutat       Date:  2021-12-02       Impact factor: 4.700

3.  Transcription Factor 4 loss-of-function is associated with deficits in progenitor proliferation and cortical neuron content.

Authors:  Antonio P Camargo; Janaina S de Souza; Vinicius M A Carvalho; Ryan A Szeto; Erin LaMontagne; Fabio Papes; José R Teixeira; Simoni H Avansini; Sandra M Sánchez-Sánchez; Thiago S Nakahara; Carolina N Santo; Wei Wu; Hang Yao; Barbara M P Araújo; Paulo E N F Velho; Gabriel G Haddad; Alysson R Muotri
Journal:  Nat Commun       Date:  2022-05-02       Impact factor: 17.694

4.  Composite Sleep Problems Observed Across Smith-Magenis Syndrome, MBD5-Associated Neurodevelopmental Disorder, Pitt-Hopkins Syndrome, and ASD.

Authors:  Anusha Gandhi; Dihong Zhou; Joseph Alaimo; Edwin Chon; Michael D Fountain; Sarah H Elsea
Journal:  J Autism Dev Disord       Date:  2021-06

5.  Daughterless, the Drosophila orthologue of TCF4, is required for associative learning and maintenance of the synaptic proteome.

Authors:  Laura Tamberg; Mariliis Jaago; Kristi Säälik; Alex Sirp; Jürgen Tuvikene; Anastassia Shubina; Carl Sander Kiir; Kaja Nurm; Mari Sepp; Tõnis Timmusk; Mari Palgi
Journal:  Dis Model Mech       Date:  2020-07-30       Impact factor: 5.758

6.  Pitt-Hopkins syndrome: phenotypic and genotypic description of four unrelated patients and structural analysis of corresponding missense mutations.

Authors:  Tingting Zhao; Georgi Z Genchev; Shengnan Wu; Guangjun Yu; Hui Lu; Jincai Feng
Journal:  Neurogenetics       Date:  2021-06-14       Impact factor: 2.660

Review 7.  Molecular and Cellular Function of Transcription Factor 4 in Pitt-Hopkins Syndrome.

Authors:  Huei-Ying Chen; Joseph F Bohlen; Brady J Maher
Journal:  Dev Neurosci       Date:  2021-06-16       Impact factor: 3.421

8.  Region and Cell Type Distribution of TCF4 in the Postnatal Mouse Brain.

Authors:  Hyojin Kim; Noah C Berens; Nicole E Ochandarena; Benjamin D Philpot
Journal:  Front Neuroanat       Date:  2020-07-17       Impact factor: 3.856

9.  Pitt-Hopkins Syndrome: Clinical and Molecular Findings of a 5-Year-Old Patient.

Authors:  Florin Tripon; Alina Bogliș; Cristian Micheu; Ioana Streață; Claudia Bănescu
Journal:  Genes (Basel)       Date:  2020-05-28       Impact factor: 4.096

10.  Behavioural and psychological characteristics in Pitt-Hopkins syndrome: a comparison with Angelman and Cornelia de Lange syndromes.

Authors:  Alice Watkins; Stacey Bissell; Jo Moss; Chris Oliver; Jill Clayton-Smith; Lorraine Haye; Mary Heald; Alice Welham
Journal:  J Neurodev Disord       Date:  2019-10-05       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.